Sponsors Can Charge For IND Drugs If They Offer "Significant Advantage"
FDA's final regulation on charging for IND drugs creates criteria for sponsors to charge for drugs other than their own during clinical trials
FDA's final regulation on charging for IND drugs creates criteria for sponsors to charge for drugs other than their own during clinical trials